Diabetes Drug R&D Services ace

Inquiry

* First Name
* Last Name
* Business Email
Phone
Company/Institution
Job Title
* Services or Products of Interest Toxicology Assessment Services for Antidiabetic Drugs
When do you expect your project to start?
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.

Toxicology Assessment Services for Antidiabetic Drugs

Ace Therapeutics provides non-GLP toxicology studies to evaluate the safety profile of antidiabetic drugs candidates. We have developed a comprehensive platform for early-stage toxicology studies of antidiabetic drugs, enabling us to conduct a range of tests, including single-dose toxicity tests, repeated-dose toxicity tests, immunotoxicity tests, local tolerance tests, and carcinogenicity tests, for our clients. Our streamlined processes and reliable data enable informed decision-making and optimized study designs for antidiabetic drugs.

Overview of Non-GLP Toxicology Assessment Services for Antidiabetic Drugs

Non-GLP toxicological tests refer to assessments conducted without adhering to GLP (Good Laboratory Practice) standards. These tests are widely utilized for preliminary toxicological assessments, including tolerance, dose-range exploration and acute toxicity tests, to facilitate the successful implementation of a regulatory compliant trial program. The objective of these tests is to ascertain the relationship between different dose levels administered and adverse effects, as well as to determine whether any potential target organs or functions may be affected.

Our Toxicology Assessment Services for Antidiabetic Drugs

Ace Therapeutics' toxicology team has extensive experience in designing and executing preclinical toxicology studies, animal health monitoring, and pathological examinations. We assist you in the successful implementation of regulatory-compliant toxicology testing programs, thereby reducing the time required for your antidiabetic drug development decisions.

Below is a list of non-GLP toxicological tests we offer for antidiabetic drugs.

Single dose toxicity test	Evaluation of toxic reactions to antidiabetic drugs over time following a single dose or multiple doses over 24 hours. Single dose toxicity test in rodents Single dose toxicity test in non-rodents
Repeated dose toxicity test	Evaluation of the toxicity profile of an animal after repeated exposure to a subject. Repeated-dose toxicity test in rodents Repeated-dose toxicity test in non-rodents
Immunotoxicity test	Evaluation of the adverse effects of antidiabetic drugs on the immune system. Cytotoxicity test Lymphocyte functional analysis Immunohistochemical test Immunohistopathological analysis
Local tolerance test	In vitro hemolysis assay Irritation test Active/passive allergenicity testing
Carcinogenicity studies	Evaluation of the carcinogenic potential of chronic exposure to antidiabetic drugs in rodents.
Genetic toxicology studies	Ames test Chromosome aberration test In vivo genotoxicity assays Mammalian cell in vitro micronucleus assay Mutagenesis assays Rodent micronucleus assay
Pancreatic toxicology analysis services	Pancreatic function tests: blood glucose level monitoring, insulin and glucagon measurement Pancreatic histopathological examination: observation of pancreatic tissue sections, immunohistochemical analysis Pancreatic islet cell function test: Detect the insulin-secreting function and glucose uptake ability of islet cells under the action of drugs.

Advantages of Our Toxicology Assessment Services

Our safety assessment research team has extensive practical experience. Whether it is a small molecule antidiabetic drug or a biologic, we can provide individualized trial design solutions.
Our advanced testing technology platform covers a range of analytical technologies, including LC-MS/MS, ELISA, qPCR, in vivo imaging, flow-through detection, and more.
Our project managers enhance the client experience through scientific excellence, superior quality, and timely delivery.

Ace Therapeutics' non-GLP toxicology study services help clients assess the safety of their antidiabetic drug candidates and the potential risks associated with their use. We can support your antidiabetic drug development decisions by delivering high-quality data within the agreed timeframe. Please feel free to contact us.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Related Services